Company Lipum AB

LIPUM

SE0015660899

Pharmaceuticals

Business Summary

Managers

Members of the board

Share class

Company contact information

Sector

Annual profits - Rate of surprise

Sector Biopharmaceuticals

Market Closed - Nasdaq Stockholm Other stock markets 12:00:00 2024-06-26 EDT			5-day change	1st Jan Change
8.65 ^SEK	+0.58%		+0.58%	+32.67%

06-18	Lipum AB Completes Multiple Dose Part of the Phase I Clinical Study	CI
05-28	Lipum AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Lipum AB (publ) is a Sweden-based biopharmaceutical company specialized in discovery and development of new treatment for chronic inflammatory diseases. Lipum develops new biological medicine for treatment of chronic inflammatory diseases eg rheumatoid arthritis. Development is based on results from preclinical research, for example in well-established animal models for inflammatory arthritis. The prospective drug is an antibody directed against a new target molecule, the protein Bile Salt-Stimulated Lipase (BSSL). Lipum's antibody (SOL-116) has a different mechanism of action than the other drugs. Lipum's drug candidate SOL-116 is a humanized monoclonal antibody and is therefore categorized as a biological drug.

Number of employees: 5

Managers	Title	Age	Since
Ola Sandborgh CEO	Chief Executive Officer	-	11-30
Susanne Eva Lindqvist FOU	Founder	64	10-06-16
Olle Carl Hernell FOU	Founder	79	10-06-16
Sonja Marina Norberg DFI	Director of Finance/CFO	60	20-12-31
Pernilla Abrahamsson COO	Chief Operating Officer	52	18-12-31
Einar Pontén PRN	Corporate Officer/Principal	63	15-12-31

Members of the board	Title	Age	Since
Gustav Ingemar Kihlström BRD	Director/Board Member	71	20-12-31
Carl-Johan Spak BRD	Director/Board Member	68	22-12-31
Kristian Sandberg BRD	Director/Board Member	-	18-12-31
Åsa Kristina Hansdotter BRD	Director/Board Member	50	20-12-31
Ulf Björklund CHM	Chairman	68	15-12-31
Olle Carl Hernell FOU	Founder	79	10-06-16

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	37,258,740	16,710,531 ( 44.85 %)	0	44.85 %

Lipum AB

Tvistevägen 48C

907 36, Umeå

+46 9 03 40 34 30

http://www.lipum.se

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Biopharmaceuticals

	1st Jan change	Capi.
LIPUM AB	+32.67%	17.34M
CSL LIMITED	+2.87%	94.22B
SAMSUNG BIOLOGICS CO.,LTD.	-4.08%	37.76B
BIOGEN INC.	-13.80%	32.5B
UCB	+73.38%	27.75B
BIOMARIN PHARMACEUTICAL INC.	-11.65%	16.13B
INCYTE CORPORATION	-0.67%	14.19B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-11.67%	11.42B
ALTEOGEN INC.	+190.36%	11.06B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-52.61%	9.09B